Pulmonary Fibrosis
X-ray technology creates clearer picture of lung changes that occur in long COVID
With advanced X-rays and blood biomarkers, researchers have found how lung tissue scarring in patients with COVID and pulmonary fibrosis forms a distinctive form of fibrotic interstitial lung disease, according to a study in eBioMedicine.
Air pollution raises mortality risk, worsens lung function in fibrotic ILD
In patients with fibrotic interstitial lung disease, exposure to small particulate matter was linked to increased mortality, poor lung function and faster disease progression, according to a study in JAMA Internal Medicine.
‘Time lost is lung lost’: Early diagnosis critical in pulmonary fibrosis
NASHVILLE, Tenn. — Delayed diagnosis of pulmonary fibrosis is an unfortunate reality for many patients, but experts are seeking to address this problem by closing knowledge gaps and increasing awareness of the disease.
Patients with IPF who experience in-hospital cardiac arrest face increased mortality rate
NASHVILLE, Tenn. — Idiopathic pulmonary fibrosis appeared associated with increased mortality rates and worse outcomes among in-hospital cardiac arrest survivors, according to study results presented at the CHEST Annual Meeting.
Patients with ILD living in rural areas do not have worse outcomes, study finds
NASHVILLE, Tenn. — People with interstitial lung disease living in rural areas do not appear to have greater risk for death, lung transplant, acute exacerbation or disease progression compared with those in urban areas, researchers reported.
ILD Day: Recent updates in treatment, management of interstitial lung disease
Sept. 14 marks the second annual ILD Day, which aims to increase awareness of interstitial lung diseases.
Top news of August: Smoking quit attempts, cesarean birth raises future asthma risk and more
The Healio Editors compiled the most-read news in pulmonology posted in August.
Electronic monitoring can be useful to assess IPF medication nonadherence, timing
Use of electronic monitoring systems helped identify prevalent medication nonadherence in patients with idiopathic pulmonary fibrosis taking pirfenidone, according to data published in ERJ Open Research.
Environmental exposures common in people with pulmonary fibrosis
Among individuals with familial pulmonary fibrosis, environmental exposures are common, vary by sex and influence the CT pattern, timing of disease onset and mortality, researchers reported.
ATS issues new clinical practice guideline on IPF, progressive fibrotic ILDs
SAN FRANCISCO — A session at the American Thoracic Society International Conference highlighted a new clinical practice guideline addressing idiopathic pulmonary fibrosis and progressive pulmonary fibrosis in adults.